Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Foersom Genetik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.5% 0.5% 0.8% 1.2% 2.5% 0.9% 4.3% 4.3%   Credit score (0-100)   99 99 92 80 62 87 48 48   Credit rating   AAA AAA AA A BBB A BBB BBB   Credit limit (kDKK)   3,265.2 3,341.6 2,603.9 588.5 0.1 2,029.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   9,687 10,608 7,169 5,927 1,885 7,294 0.0 0.0   EBITDA   4,434 5,063 2,270 1,100 -3,111 1,728 0.0 0.0   EBIT   3,319 3,877 1,037 -368 -4,215 58.0 0.0 0.0   Pre-tax profit (PTP)   3,390.2 3,132.4 413.9 -117.7 -3,655.1 163.1 0.0 0.0   Net earnings   2,583.6 2,212.5 227.7 -7.0 -2,787.2 29.1 0.0 0.0   Pre-tax profit without non-rec. items   3,390 3,132 414 -118 -3,655 163 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   8,912 7,932 6,612 5,790 5,339 4,762 0.0 0.0   Shareholders equity total   27,365 28,828 28,305 28,298 25,511 25,540 25,415 25,415   Interest-bearing liabilities   742 0.0 553 937 0.0 0.0 0.0 0.0   Balance sheet total (assets)   32,414 34,099 32,214 32,001 28,424 29,238 25,415 25,415   Net Debt   -7,728 -5,606 -3,886 -4,101 -1,396 -6,653 -19,621 -19,621     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   9,687 10,608 7,169 5,927 1,885 7,294 0.0 0.0   Gross profit growth   -30.7% 9.5% -32.4% -17.3% -68.2% 287.1% -100.0% 0.0%   Employees   12 13 12 12 13 13 0 0   Employee growth %   9.1% 8.3% -7.7% 0.0% 8.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   32,414 34,099 32,214 32,001 28,424 29,238 25,415 25,415   Balance sheet change%   7.2% 5.2% -5.5% -0.7% -11.2% 2.9% -13.1% 0.0%   Added value   4,433.8 5,062.7 2,269.8 1,100.2 -2,746.1 1,349.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -912 -2,166 -2,553 -2,481 -1,999 -1,963 -4,762 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   34.3% 36.5% 14.5% -6.2% -223.6% 0.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.0% 11.8% 3.3% -0.3% -11.9% 0.6% 0.0% 0.0%   ROI %   12.2% 12.9% 3.5% -0.3% -12.3% 0.6% 0.0% 0.0%   ROE %   9.9% 7.9% 0.8% -0.0% -10.4% 0.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   84.4% 84.5% 87.9% 88.4% 89.8% 87.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -174.3% -110.7% -171.2% -372.8% 44.9% -385.1% 0.0% 0.0%   Gearing %   2.7% 0.0% 2.0% 3.3% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   18.9% 210.9% 243.1% 2.5% 11.2% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.6 5.0 9.2 9.4 13.0 6.3 0.0 0.0   Current Ratio   5.6 5.8 10.2 11.2 17.9 8.5 0.0 0.0   Cash and cash equivalent   8,470.0 5,606.0 4,438.7 5,038.6 1,395.7 6,653.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   10,130.5 13,209.9 14,064.7 14,777.8 15,498.3 15,721.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   369 389 189 92 -211 104 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   369 389 189 92 -239 133 0 0   EBIT / employee   277 298 86 -31 -324 4 0 0   Net earnings / employee   215 170 19 -1 -214 2 0 0